Abandoning empirical antibiotics for febrile children [15]

Lancet

Volumn 350, Issue 9080, 1997, Pages 811-812

  Pollard, A J ^a   DeMunter, C ^a   Nadel, S ^a   Levin, M ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; HAEMOPHILUS INFLUENZAE TYPE B VACCINE;

ANTIBIOTIC THERAPY; AUSTRALIA; BACTERIAL MENINGITIS; BLOOD CULTURE; CHILD; CHILDHOOD DISEASE; DRUG EFFICACY; FEVER; GENERAL PRACTITIONER; HAEMOPHILUS INFLUENZAE TYPE B; HEALTH CARE ACCESS; HUMAN; LETTER; LEUKOCYTE COUNT; MENINGOCOCCOSIS; NEW ZEALAND; PENICILLIN RESISTANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; UNITED KINGDOM; UNITED STATES; URINE CULTURE;

EID: 0030931055     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)62604-9     Document Type: Letter

References (5)

1. JK Stamos ST Shulman Abandoning empirical antibiotics for febrile children Lancet 350 1997 84
2. Noah N, Connolly C. Surveillance of bacterial meningitis in Europe 1995. London: King's European Meningitis Surveillance Unit, King's College Hospital, 1996: 8.
3. LA Jackson JD Wenger Laboratory-based surveillance of meningococcal disease in selected areas, United States 1989–91 MMWR 42 1993 21 30
4. TC Boswell D Frodsham KJ Nye EG Smith Antibiotic resistance and serotypes of Streptococcus pneumoniae at Birmingham Public Health Laboratory, 1989–94 J Infect 33 1996 17 22
5. GJ Browne JM Ryan P McIntyre Evaluation of a protocol for empiric treatment of fever without localising signs Arch Dis Child 76 1997 129 133